PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $622 | -35.5% | 27,976 | +16.6% | 0.00% | -50.0% |
| Q2 2023 | $964 | -16.8% | 24,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $1,158 | +31.4% | 24,000 | 0.0% | 0.00% | +50.0% |
| Q4 2022 | $881 | -99.9% | 24,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $1,198,000 | +79.6% | 24,000 | +42.9% | 0.00% | +100.0% |
| Q2 2022 | $667,000 | +6.4% | 16,800 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $627,000 | +2.1% | 16,800 | +9.8% | 0.00% | +100.0% |
| Q4 2021 | $614,000 | +11.8% | 15,300 | +2.7% | 0.00% | -50.0% |
| Q3 2021 | $549,000 | -11.2% | 14,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $618,000 | -10.4% | 14,900 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $690,000 | -50.7% | 14,900 | -32.0% | 0.00% | -60.0% |
| Q4 2020 | $1,401,000 | -45.4% | 21,900 | -60.2% | 0.01% | -54.5% |
| Q3 2020 | $2,567,000 | – | 55,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |